#medicines

Value Added Medicines Today Value Added Medicines contribute to addressing unmet patient needs. Moving from a one-size-fits-all to a much more tailored and patient specific approach, value added medicines are one of the key components of the customis

Medicines for Europe represents pharmaceutical companies supplying the largest share of prescription medicines across Europe and is the voice of the generic, biosimilar and value added medicines industries.

Generic medicines today The generic medicines industry is at the heart of public health delivery. This industry provides essential medicines that European patients, healthcare professionals and healthcare systems rely on to treat most acute and chron

Biosimilar Medicines Today Biosimilar medicines were invented in Europe 20 years ago to address the pressing need for better access to biopharmaceuticals in Europe. For example, a recent study demonstrated the inequity in access to biologic medicines